Follow
Vera Huang
Vera Huang
Senior Director, Research
Verified email at ractigen.com
Title
Cited by
Cited by
Year
Upregulation of Cyclin B1 by miRNA and its implications in cancer
V Huang, RF Place, V Portnoy, J Wang, Z Qi, Z Jia, A Yu, M Shuman, J Yu, ...
Nucleic acids research 40 (4), 1695-1707, 2012
3222012
RNAa is conserved in mammalian cells
V Huang, Y Qin, J Wang, X Wang, RF Place, G Lin, TF Lue, LC Li
PloS one 5 (1), e8848, 2010
2222010
Small RNA and transcriptional upregulation
V Portnoy, V Huang, RF Place, LC Li
Wiley Interdisciplinary Reviews: RNA 2 (5), 748-760, 2011
1882011
Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration
J Wang, RF Place, V Huang, X Wang, EJ Noonan, CE Magyar, J Huang, ...
Cancer research 70 (24), 10182-10191, 2010
1612010
Ago1 Interacts with RNA polymerase II and binds to the promoters of actively transcribed genes in human cancer cells
V Huang, J Zheng, Z Qi, J Wang, RF Place, J Yu, H Li, LC Li
PLoS genetics 9 (9), e1003821, 2013
1442013
Structure-based design of pyridone–aminal eFT508 targeting dysregulated translation by selective mitogen-activated protein kinase interacting kinases 1 and 2 (MNK1/2) inhibition
SH Reich, PA Sprengeler, GG Chiang, JR Appleman, J Chen, J Clarine, ...
Journal of medicinal chemistry 61 (8), 3516-3540, 2018
1352018
Cystic fibrosis airway epithelial cell polarity and bacterial flagellin determine host response to Pseudomonas aeruginosa
K Hybiske, JK Ichikawa, V Huang, SJ Lory, TE Machen
Cellular microbiology 6 (1), 49-63, 2004
962004
miRNA goes nuclear
V Huang, LC Li
RNA biology 9 (3), 269-273, 2012
802012
Demystifying the nuclear function of Argonaute proteins
V Huang, LC Li
RNA biology 11 (1), 18-24, 2014
632014
Formulation of small activating RNA into lipidoid nanoparticles inhibits xenograft prostate tumor growth by inducing p21 expression
RF Place, J Wang, EJ Noonan, R Meyers, M Manoharan, K Charisse, ...
Molecular Therapy-Nucleic Acids 1, 2012
632012
Induction of NANOG expression by targeting promoter sequence with small activating RNA antagonizes retinoic acid-induced differentiation
X Wang, J Wang, V Huang, RF Place, LC Li
Biochemical Journal 443 (3), 821-828, 2012
532012
Non-invasive characterization of human bone marrow stimulation and reconstitution by cell-free messenger RNA sequencing
A Ibarra, J Zhuang, Y Zhao, NS Salathia, V Huang, AD Acosta, J Aballi, ...
Nature communications 11 (1), 400, 2020
492020
Targeted induction of endogenous NKX3‐1 by small activating RNA inhibits prostate tumor growth
S Ren, MR Kang, J Wang, V Huang, RF Place, Y Sun, LC Li
The Prostate 73 (14), 1591-1601, 2013
492013
RNAa in action: from the exception to the norm
D Guo, L Barry, SSH Lin, V Huang, LC Li
RNA biology 11 (10), 1221-1225, 2014
402014
Inducing gene expression by targeting promoter sequences using small activating RNAs
J Wang, RF Place, V Portnoy, V Huang, MR Kang, M Kosaka, MKC Ho, ...
Journal of biological methods 2 (1), 2015
322015
eFT508, a Potent and Selective Mitogen-Activated Protein Kinase Interacting Kinase (MNK) 1 and 2 Inhibitor, Is Efficacious in Preclinical Models of Diffuse Large B-Cell …
ASH 2015 Annual Meeting 126 (23), 1554, 2015
28*2015
Identification of Small Activating RNAs that Enhance Endogenous OCT4 Expression in Human Mesenchymal Stem Cells
J Wang, V Huang, L Ye, A Bárcena, G Lin, TF Lue, LC Li
Stem cells and development 24 (3), 345-353, 2015
222015
Endogenous miRNAa: miRNA-mediated gene upregulation
V Huang
RNA Activation, 65-79, 2017
182017
Effect of hydroxyurea on the promoter occupancy profiles of tumor suppressor p53 and p73
V Huang, X Lu, Y Jiang, JYJ Wang
BMC biology 7, 1-16, 2009
52009
eFT508: an oral, potent and highly selective inhibitor of MNK1 and MNK2, promotes anti-tumor immunity as a monotherapy and in combination with immune checkpoint blockade
KR Webster, VK Goel, J Staunton, INJ Hung, GS Parker, CR Stumpf, ...
CANCER RESEARCH 77, 2017
22017
The system can't perform the operation now. Try again later.
Articles 1–20